JULIET KYOTOWADDE: Open Payments
NPI 1780324202 · METHUEN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 34 payments from 9 companies in 2025. Trend: 2023 $759 · 2024 $786 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $282 |
| Janssen Pharmaceuticals, Inc | 4 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Lundbeck LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $22 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, INVEGA SUSTENNA, SPRAVATO, Auvelity, UZEDY.
Industry payments across MA — which companies pay providers there.
